See more : Litemax Electronics Inc. (4995.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Perimeter Medical Imaging AI, Inc. (PYNKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Perimeter Medical Imaging AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Sensirion Holding AG (SENS.SW) Income Statement Analysis – Financial Results
- Pharming Group N.V. (PHAR) Income Statement Analysis – Financial Results
- China Pipe Group Limited (0380.HK) Income Statement Analysis – Financial Results
- JJ Entertainment SE (JJSE.VI) Income Statement Analysis – Financial Results
- DNAPrint Genomics, Inc. (DNAG) Income Statement Analysis – Financial Results
Perimeter Medical Imaging AI, Inc. (PYNKF)
About Perimeter Medical Imaging AI, Inc.
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. was founded in 2013 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 403.53K | 132.77K | 11.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 197.11K | 32.14K | 6.30K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 206.42K | 100.63K | 5.04K | -47.57K | -51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 51.15% | 75.79% | 44.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 6.83M | 5.48M | 4.50M | 468.31K | 643.35K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.12M | 5.45M | 7.89M | 8.84M | 7.51M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 4.96M | 4.84M | 3.67M | 122.94K | 36.78K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 14.68M | 10.28M | 11.56M | 8.96M | 7.54M | 135.62K | 123.44K | 137.17K | 184.42K |
| Other Expenses | 0.00 | 463.68K | 3.57K | 629.17K | 376.57K | 20.42K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.51M | 16.22M | 16.06M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
| Cost & Expenses | 21.58M | 16.25M | 16.07M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
| Interest Income | 0.00 | 0.00 | 10.36K | 6.90K | 4.65K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 104.93K | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 614.70K | 1.04M | 93.84K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -13.28M | -11.72M | -15.95M | -6.11M | -7.01M | -115.20K | -123.44K | -137.17K | -184.42K |
| EBITDA Ratio | -3,290.15% | -11,539.44% | -140,655.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -20.73M | -16.12M | -16.05M | -11.67M | -13.02M | -115.20K | -123.44K | -137.17K | -184.42K |
| Operating Income Ratio | -5,137.06% | -12,142.65% | -141,482.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.79M | 6.22M | -3.86M | 2.13M | -2.22M | 820.86K | 1.70M | -4.70M | -107.31K |
| Income Before Tax | -18.94M | -9.91M | -16.65M | -7.89M | -10.34M | 705.67K | 1.58M | -4.83M | -291.73K |
| Income Before Tax Ratio | -4,694.58% | -7,461.33% | -146,802.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 2.00 | -6.32M | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -18.94M | -3.59M | -16.76M | -8.00M | -10.50M | 705.67K | 1.58M | -4.83M | -291.73K |
| Net Income Ratio | -4,694.58% | -2,700.97% | -147,774.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
| EPS Diluted | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
| Weighted Avg Shares Out | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
| Weighted Avg Shares Out (Dil) | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
Perimeter Medical Imaging AI Announces Further Commercial Expansion in North Texas with Follow-On Placement of Perimeter S-Series OCT within National Healthcare Provider System
DALLAS and TORONTO , Dec. 14, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced a follow-on commercial placement of its flagship Perimeter S-Series OCT...
Perimeter Medical Imaging AI Announces Investor Webinar Featuring Breast Surgeon KOL to Discuss Re-excision Epidemic and Potential Benefits of AI in Cancer Surgery
DALLAS and TORONTO , Nov. 27, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced that it will participate in an investor webinar hosted by...
Perimeter Medical Imaging AI, Inc. (PYNKF) Q3 2023 Earnings Call Transcript
Perimeter Medical Imaging AI, Inc. (OTCPK:PYNKF) Q3 2023 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants Jodi Regts - IR Adrian Mendes - CEO Conference Call Participants Rahul Sarugaser - Raymond James Operator Good afternoon, ladies and...
Perimeter Medical Imaging AI ends 3Q with US$18M cash and equivalents; advances next-gen AI
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) has announced its third quarter 2023 financial results, ending the period with cash and cash equivalents of US$18,105,837 as of September 30, 2023. The commercial-stage medical technology company also its net loss for the quarter improve...
Perimeter Medical Imaging AI Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Company Announces Appointment of Adrian Mendes to Board of Directors Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , Nov. 14, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a...
Perimeter Medical Imaging AI initiates new clinical trial site at University of Washington's Fred Hutch Cancer Center
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) said it has initiated an additional clinical trial site at the Fred Hutch Cancer Center at the University of Washington in Seattle as part of an ongoing multi-center, randomized two-arm pivotal clinical trial. The company...
Perimeter Medical Imaging AI Announces Initiation of New Clinical Trial Site at University of Washington/Fred Hutch Cancer Center
DALLAS and TORONTO , Oct. 31, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced the initiation of an additional clinical trial site at the University...
Perimeter Medical Imaging AI to Host Investor Webcast on October 25, 2023 at 2 pm ET
DALLAS and TORONTO , Oct. 17, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced that it will host an investor webcast presentation on Wednesday,...
Perimeter Medical Imaging AI says patient randomization is underway at Florida clinical trial site
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) told investors that patient randomization is underway at Mayo Clinic in Florida, the most recent clinical site to be initiated as part of an ongoing multi-center, randomized two-arm pivotal clinical trial. The trial is evaluating...
Perimeter Medical Imaging AI Announces Patient Randomization Underway at Clinical Trial Site at Mayo Clinic in Florida
DALLAS and TORONTO , Oct. 11, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that patient randomization is underway at Mayo Clinic in Florida,...
Source: https://incomestatements.info
Category: Stock Reports